000 01498 a2200433 4500
005 20250513073148.0
264 0 _c19930902
008 199309s 0 0 eng d
022 _a0194-911X
024 7 _a10.1161/01.hyp.22.2.221
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSmits, G J
245 0 0 _aAngiotensin subtype 1 blockade selectively potentiates adenosine subtype 2-mediated vasodilation.
_h[electronic resource]
260 _bHypertension (Dallas, Tex. : 1979)
_cAug 1993
300 _a221-30 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenosine
_xanalogs & derivatives
650 0 4 _aAngiotensin II
_xantagonists & inhibitors
650 0 4 _aAnimals
650 0 4 _aBiphenyl Compounds
_xpharmacology
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aImidazoles
_xpharmacology
650 0 4 _aInjections, Intravenous
650 0 4 _aLosartan
650 0 4 _aMale
650 0 4 _aNifedipine
_xpharmacology
650 0 4 _aNitroglycerin
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aTetrazoles
_xpharmacology
650 0 4 _aVascular Resistance
_xdrug effects
650 0 4 _aVasodilation
_xdrug effects
700 1 _aKitzen, J M
700 1 _aPerrone, M H
700 1 _aCox, B F
773 0 _tHypertension (Dallas, Tex. : 1979)
_gvol. 22
_gno. 2
_gp. 221-30
856 4 0 _uhttps://doi.org/10.1161/01.hyp.22.2.221
_zAvailable from publisher's website
999 _c8339434
_d8339434